Delivery Systems, Cargo Engineering, and In Vivo Constraints
Delivery Is the Bottleneck
Why Delivery Dominates Translation
Even the most powerful editor is useless if it cannot reach the correct cells, at the right dose, with acceptable toxicity and enough expression time to act. Delivery determines tissue specificity, editing kinetics, immune activation, biodistribution, and the feasibility of repeated dosing.
Common Delivery Platforms
| Platform | Strengths | Limitations |
|---|---|---|
| AAV | Efficient in many tissues and widely used in vivo | Limited cargo capacity, pre-existing immunity, and payload constraints |
| Lentiviral vectors | Useful for stable integration and ex vivo work | Integration risks and payload considerations |
| Lipid nanoparticles | Non-viral, scalable, adaptable for RNA or RNP delivery | Tissue specificity and endosomal escape remain challenging |
| Electroporation | Highly effective ex vivo for many cell types | Not suitable for most in vivo applications |
| Virus-like particles | Transient delivery of protein or RNP cargo | Manufacturing and targeting are still maturing |
Cargo Engineering Challenges
Large editors can exceed vector capacity, so researchers split components, minimize regulatory sequences, use compact Cas orthologs, or shift to protein/RNP delivery. For in vivo use, promoter choice, codon optimization, nuclear localization, and payload stoichiometry can materially change results.
Delivery Strategy Tradeoffs
Viral Delivery
- Often strong in vivo transduction
- Can be durable and tissue-tropic
- May raise immunogenicity and payload constraints
Non-Viral Delivery
- Potentially safer and more transient
- Flexible cargo forms such as RNA or RNP
- May struggle with tissue selectivity and efficiency
Which delivery approach is often preferred for transient ex vivo genome editing of harvested cells?
Electroporation of ribonucleoprotein complexes is widely used ex vivo because it is transient, efficient, and avoids prolonged nuclease expression.
Correct answer: Electroporation of RNP complexes
What is a major engineering limitation of adeno-associated virus as a delivery vehicle?
AAV has a relatively small packaging capacity, which constrains the size of cargo that can be delivered.
Correct answer: Its cargo capacity is limited
Why is tissue specificity a central issue for in vivo genetic engineering?
Spatial control is essential for both efficacy and safety.
Correct answer: Because off-target biodistribution can cause ineffective dosing in the intended tissue and unintended editing elsewhere.
Name one reason lipid nanoparticles are attractive for genome engineering delivery.
Their modular chemistry makes them useful for scalable, potentially repeat-dose applications.
Correct answer: They are non-viral and can deliver RNA or RNP cargo transiently.
Frontier Direction
A major frontier is programmable delivery: designing vehicles that recognize cell-surface markers, evade immunity, and deliver editors only to the cells that should be modified.